Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express

Yesterday

Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes:

• Reviewing and approving the consolidated annual results for the year ended 31 December 2025.

• Considering a recommendation on the payment of a final dividend, if any.

• Addressing other routine corporate matters.

Dr. Xu Qi, Chairwoman and Chief Executive Officer, signed the notice on behalf of the board.

Board composition as at the date of the announcement: – Executive Directors: Dr. Xu Qi, Dr. Li Xiang, Ms. Li Xiangli, Ms. Cheng Tao, and Ms. Li Lingmei. – Non-executive Director: Mr. Wu Yihui. – Independent Non-executive Directors: Dr. Yu Cheung Hoi, Dr. Zhu Xun, and Mr. Xia Xinsheng.

The company emphasised that the annual results announcement and any dividend decisions will be published following board approval on 30 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1153266924"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153266924\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153266924?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 23:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153266924","market":"hk","top_or_hot":-1,"title":"Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the year ended 31 December 2025.</p>\n<p>• Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>• Addressing other routine corporate matters.</p>\n<p>Dr. Xu Qi, Chairwoman and Chief Executive Officer, signed the notice on behalf of the board.</p>\n<p>Board composition as at the date of the announcement:  \n– Executive Directors: Dr. Xu Qi, Dr. Li Xiang, Ms. Li Xiangli, Ms. Cheng Tao, and Ms. Li Lingmei.  \n– Non-executive Director: Mr. Wu Yihui.  \n– Independent Non-executive Directors: Dr. Yu Cheung Hoi, Dr. Zhu Xun, and Mr. Xia Xinsheng.</p>\n<p>The company emphasised that the annual results announcement and any dividend decisions will be published following board approval on 30 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the year ended 31 December 2025.</p>\n<p>• Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>• Addressing other routine corporate matters.</p>\n<p>Dr. Xu Qi, Chairwoman and Chief Executive Officer, signed the notice on behalf of the board.</p>\n<p>Board composition as at the date of the announcement:  \n– Executive Directors: Dr. Xu Qi, Dr. Li Xiang, Ms. Li Xiangli, Ms. Cheng Tao, and Ms. Li Lingmei.  \n– Non-executive Director: Mr. Wu Yihui.  \n– Independent Non-executive Directors: Dr. Yu Cheung Hoi, Dr. Zhu Xun, and Mr. Xia Xinsheng.</p>\n<p>The company emphasised that the annual results announcement and any dividend decisions will be published following board approval on 30 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03880","symbol_name":"泰德医药","start_time":0,"source_url":"","article_id":"1153266924","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153266924","pubTimestamp":1773673303,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes: • Reviewing and approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03880":"泰德医药"},"translate_title":"Medtide Inc.(03880)定于2026年3月30日召开董事会批准2025财年业绩和股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03880":1},"content_text":"Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes:\n• Reviewing and approving the consolidated annual results for the year ended 31 December 2025.\n• Considering a recommendation on the payment of a final dividend, if any.\n• Addressing other routine corporate matters.\nDr. Xu Qi, Chairwoman and Chief Executive Officer, signed the notice on behalf of the board.\nBoard composition as at the date of the announcement:  \n– Executive Directors: Dr. Xu Qi, Dr. Li Xiang, Ms. Li Xiangli, Ms. Cheng Tao, and Ms. Li Lingmei.  \n– Non-executive Director: Mr. Wu Yihui.  \n– Independent Non-executive Directors: Dr. Yu Cheung Hoi, Dr. Zhu Xun, and Mr. Xia Xinsheng.\nThe company emphasised that the annual results announcement and any dividend decisions will be published following board approval on 30 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}